Pharmacokinetics and delayed experimental antithrombotic effect of two domain non-glycosylated tissue factor pathway inhibitor
- 15 February 1996
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 81 (4) , 461-470
- https://doi.org/10.1016/0049-3848(96)00018-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Tissue Factor Pathway: How It Has Become a “Prima Ballerina”Thrombosis and Haemostasis, 1995
- Tissue Factor Pathway InhibitorThrombosis and Haemostasis, 1995
- Effect of Carbohydrates on the Pharmacokinetics of Human Interferon-γJournal of Interferon Research, 1993
- In vivo clearance of tissue plasminogen activator: The complex role of sites of glycosylation and level of sialylationFibrinolysis, 1993
- Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitorNature, 1989
- Modifications of Extrinsic Pathway Inhibitor (EPI) and Factor Xa that Affect their Ability to Interact and to Inhibit Factor Vila/Tissue Factor: Evidence for a Two-Step Model of InhibitionThrombosis and Haemostasis, 1988
- Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)Thrombosis Research, 1988
- The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of actionBlood, 1988
- A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractionsThrombosis Research, 1987
- A pharmacokinetic analysis program (multi) for microcomputer.Journal of Pharmacobio-Dynamics, 1981